Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublication citation added: Hanna GJ et al. Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026 Feb 26:e255404. doi:10.1001/jamaoto.2025.5404. Online ahead of print. The previous entry for this publication was removed.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check42 days agoChange DetectedResults Submitted replaces No Results Posted on the study page, indicating that the study results have been submitted.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2; no visible changes to study content or page layout.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a Publications entry with the JAMA Otolaryngol Head Neck Surg article citation for the study, and noted that publications are automatically filled from PubMed.SummaryDifference0.3%

- Check71 days agoChange DetectedRevision: v3.4.2 is now active, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.